LLY
911.65
+0.96%↑
JNJ
235.8
+0.14%↑
ABBV
205.01
+0.38%↑
NVS
147.58
+1.16%↑
AZN
184.25
+0.48%↑
LLY
911.65
+0.96%↑
JNJ
235.8
+0.14%↑
ABBV
205.01
+0.38%↑
NVS
147.58
+1.16%↑
AZN
184.25
+0.48%↑
LLY
911.65
+0.96%↑
JNJ
235.8
+0.14%↑
ABBV
205.01
+0.38%↑
NVS
147.58
+1.16%↑
AZN
184.25
+0.48%↑
LLY
911.65
+0.96%↑
JNJ
235.8
+0.14%↑
ABBV
205.01
+0.38%↑
NVS
147.58
+1.16%↑
AZN
184.25
+0.48%↑
LLY
911.65
+0.96%↑
JNJ
235.8
+0.14%↑
ABBV
205.01
+0.38%↑
NVS
147.58
+1.16%↑
AZN
184.25
+0.48%↑
24h
Aktuell
Min
Max
Empfehlungen | Buy |
|---|---|
12-Monats-Prognose | +203.74% upside |
Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.
23. März 2026, 23:47 UTC
Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update
DJ
Lesen
23. März 2026, 22:55 UTC
Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion
DJ
Lesen
23. März 2026, 21:51 UTC
Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update
DJ
Lesen
23. März 2026, 23:59 UTC
Global Equities Roundup: Market Talk
DJ
Lesen
23. März 2026, 23:59 UTC
Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk
DJ
Lesen
23. März 2026, 23:50 UTC
Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk
DJ
Lesen
23. März 2026, 23:37 UTC
Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk
DJ
Lesen
23. März 2026, 22:42 UTC
Global Equities Roundup: Market Talk
DJ
Lesen
23. März 2026, 22:42 UTC
Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk
DJ
Lesen
23. März 2026, 22:40 UTC
Gilead Sciences to Buy Ouro Medicines for Up to $2.18B
DJ
Lesen
23. März 2026, 22:23 UTC
Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk
DJ
Lesen
23. März 2026, 22:22 UTC
Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease
DJ
Lesen
23. März 2026, 22:21 UTC
Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales
DJ
Lesen
23. März 2026, 22:21 UTC
Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China
DJ
Lesen
23. März 2026, 22:20 UTC
Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD
DJ
Lesen
23. März 2026, 22:20 UTC
Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD
DJ
Lesen
23. März 2026, 22:19 UTC
Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders
DJ
Lesen
23. März 2026, 22:19 UTC
Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets
DJ
Lesen
23. März 2026, 22:18 UTC
Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD
DJ
Lesen
23. März 2026, 22:15 UTC
Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD
DJ
Lesen
23. März 2026, 22:08 UTC
Ebos Needs to Reset Its Gearing Targets -- Market Talk
DJ
Lesen
23. März 2026, 21:42 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Lesen
23. März 2026, 21:42 UTC
RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk
DJ
Lesen
23. März 2026, 21:32 UTC
WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK
DJ
Lesen
23. März 2026, 21:32 UTC
WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK
DJ
Lesen
23. März 2026, 21:32 UTC
WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK
DJ
Lesen
23. März 2026, 21:10 UTC
Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com
DJ
Lesen
23. März 2026, 20:50 UTC
Tech, Media & Telecom Roundup: Market Talk
DJ
Lesen
23. März 2026, 20:50 UTC
Health Care Roundup: Market Talk
DJ
Lesen
23. März 2026, 20:50 UTC
Basic Materials Roundup: Market Talk
DJ
Lesen
Kursveränderung
By TipRanks
12-Monats-Prognose
Durchschnitt 6.5 USD 203.74%
Hoch 6.5 USD
Tief 6.5 USD
Basierend auf 1 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Onconova Therapeutics Inc – Dist angeboten haben.
By TipRanks
Buy
1 ratings
1
Buy
0
Halten
0
Sell
Basierend auf 1 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Onconova Therapeutics Inc – Dist abgegeben haben.
$